MAXHEALTH vs MEDANTA: Stock Comparison
Head-to-head financial and trading comparison between Max Healthcare Institute Limited (MAXHEALTH) and Global Health Limited (MEDANTA) in the Hospitals & Diagnostics sector.
MAXHEALTH
NSE: MAXHEALTHMEDANTA
NSE: MEDANTAKey Metrics Comparison Table
| Metric | MAXHEALTH | MEDANTA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹940.95 | ₹1,357.30 | — |
| 1-Year Price Return | -1.3% | +27.31% | MEDANTA (28.61% higher) |
| 52-Week High | ₹1,153.40 | ₹1,508.90 | — |
| 52-Week Low | ₹929.80 | ₹1,061.45 | — |
| 30-Day Annualized Volatility | 30.3% | 36.04% | MAXHEALTH (Steadier) |
| 30-Day Average Daily Volume | 2,408,023 | 285,547 | MAXHEALTH (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MAXHEALTH and MEDANTA, which stock gave better returns over the last year?
MEDANTA has outperformed MAXHEALTH over the past 12 months with a gain of 27.31% compared to -1.3%.
Which stock is less volatile: MAXHEALTH or MEDANTA?
MAXHEALTH demonstrated lower price volatility (30.3% annualized) compared to MEDANTA (36.04%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MAXHEALTH vs MEDANTA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MAXHEALTH and MEDANTA direct sector competitors?
Yes, both companies operate within the Hospitals & Diagnostics sector in India and are actively tracked as sector peers by institutional and retail market participants.